Pulse Biosciences (PLSE) Research & Development (2015 - 2026)

Pulse Biosciences has reported Research & Development for 12 years, with the latest figure at $17.0 million in Q2 2026.

• On a quarterly basis, Research & Development rose 40.44% year-over-year to $17.0 million in Q2 2026; TTM through Jun 2026 was $51.4 million, a 26.05% increase from a year earlier, with the FY2025 full-year figure at $44.7 million, up 38.3% from the prior year.
• Research & Development was $17.0 million for Q2 2026 at Pulse Biosciences, up from $10.9 million in the prior quarter.
• The five-year high for Research & Development was $17.0 million in Q2 2026, with the low at $4.1 million in Q4 2022.
• Average Research & Development over 5 years is $8.4 million, with a median of $7.5 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Research & Development tumbled 30.08% in 2022, then soared 90.45% in 2023.
• Over 5 years, Research & Development stood at $4.1 million in 2022, then soared by 90.45% to $7.8 million in 2023, then soared by 36.71% to $10.7 million in 2024, then increased by 2.49% to $10.9 million in 2025, then soared by 55.36% to $17.0 million in 2026.
• The last three Research & Development figures came in at $17.0 million (Q2 2026), $10.9 million (Q4 2025), and $11.4 million (Q3 2025), per Business Quant data.